Endlyz Therapeutics

About:

Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.

Description:

ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.

Total Funding Amount:

$3.25M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2021-01-01

Founders:

Number of Employees:

Last Funding Date:

2021-07-29

IPO Status:

Private

Industries: